Back to home
REGULATORYApril 8, 2026·6 min read
Organ-on-Chip Adoption Accelerates Under FDA Modernization Act 2.0
Two years after the legislation allowing non-animal testing methods, microphysiology systems are seeing real adoption in IND-enabling studies. Three pharma companies report replacing animal tox studies with organ chips.
The full analysis is published in the weekly biotech.today newsletter — subscribe for free to get the next issue in your inbox.